Fellowship dates: 1992-1995
Research Emphasis:  Measurement of cellular adhesion under static conditions., Isolation and characterization of cell lines with genetically distinct mutations downstream of protein kinase C that result in defective activation-dependent regulation of T cell integrin function., Differential activation-dependent regulation of integrin function in cultured human T-leukemic cell lines., Regulatory mechanisms underlying T cell integrin receptor function., Distinct divalent cation requirements for integrin-mediated CD4+ T lymphocyte adhesion to ICAM-1, fibronectin, VCAM-1, and invasin.

Current Position:Founder and CSO of Nipuna Therapeutics, Brighton, Michigan